References:
[1] Hussain FA, Njoku FU, Saraf SL, Molokie RE, Gordeuk VR, Han J.
COVID-19 infection in patients with sickle cell disease. Br J Haematol
2020;189:851–2. https://doi.org/10.1111/bjh.16734.
[2] Pinto VM, Balocco M, Quintino S, Forni GL. Sickle cell disease:
a review for the internist. Intern Emerg Med 2019;14:1051–64.
https://doi.org/10.1007/s11739-019-02160-x.
[3] Gladwin MT, Vichinsky E. T 2254. Sci York 2009:2254–65.
https://doi.org/10.1164/rccm.201111-2082CI.
[4] Ramachandran P, Perisetti A, Kathirvelu B, Gajendran M, Ghanta
S, Onukogu I, et al. Low morbidity and mortality with COVID‐19 in sickle
cell disease: A single center experience. EJHaem 2020:jha2.87.
https://doi.org/10.1002/jha2.87.
[5] Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay
D. COVID-19 pneumonia as a cause of acute chest syndrome in an adult
sickle cell patient. Am J Hematol 2020;95:E154–6.
https://doi.org/10.1002/ajh.25809.
[6] Down B, Kulkarni S, Khan AHA, Barker B, Tang I. Novel
coronavirus (COVID-19) infection: What a doctor on the frontline needs
to know. Ann Med Surg 2020;55:24–9.
https://doi.org/10.1016/j.amsu.2020.05.014.
[7] Soliman AT, Prabhakaran Nair A, Al Masalamani MS, De Sanctis V,
Abu Khattab MA, Alsaud AE, et al. Prevalence, clinical manifestations,
and biochemical data of type 2 diabetes mellitus versus nondiabetic
symptomatic patients with COVID-19: A comparative study. Acta Biomed
2020;91:e2020010. https://doi.org/10.23750/abm.v91i3.10214.
[8] Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease
and assessment of risk factors based on transcranial Doppler values in
the Gulf region. Hematol (United Kingdom) 2020;25:55–62.
https://doi.org/10.1080/16078454.2020.1714113.
[9] Yassin M, Soliman A, De Sanctis V, Nashwan A, Abusamaan S,
Moustafa A, et al. Liver iron content (LIC) in adults with sickle cell
disease (SCD): Correlation with serum ferritin and liver enzymes
concentrations in transfusion dependent (TD-SCD) and non-transfusion
dependent (NT-SCD) patients. Mediterr J Hematol Infect Dis 2017;9.
https://doi.org/10.4084/mjhid.2017.037.
[10] Yassin MA, Soliman AT, de Sanctis V, Abdula MAJ, Riaz LM, Ghori
FF, et al. Statural growth and prevalence of endocrinopathies in
relation to liver iron content (LIC) in adult patients with beta
thalassemia major (BTM) and sickle cell disease (SCD). Acta Biomed
2018;89:33–40. https://doi.org/10.23750/abm.v89i2-S.7085.
[11] Shier A, Abdelrazek M, Soliman A, De Sanctis V, Elsayed A,
Abdulla M, et al. Short-Term Outcome and MRI Changes in Three Adult
Patients with Sickle Cell Disease and Aseptic Osteonecrosis after
Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report. Case Rep
Oncol 2020;13:365–72. https://doi.org/10.1159/000506330.
[12] Abdelmahmuod E, Yassin MA, Ahmed M, Ali E. The Relationship
Between Sickle Cell Disease and Sudden Onset Sensorineural Deafness.
Cureus 2020. https://doi.org/10.7759/cureus.9413.
[13] Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET,
Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle
cell disease. N Engl J Med 2000;342:1855–65.
https://doi.org/10.1056/NEJM200006223422502.
[14] Farmakis D, Giakoumis A, Cannon L, Angastiniotis M, Eleftheriou
A. COVID-19 and thalassaemia: A position statement of the Thalassaemia
International Federation. Eur J Haematol 2020:1–9.
https://doi.org/10.1111/ejh.13476.
[15] Allison D, Campbell-Lee S, Crane J, Vidanovic V, Webb S,
Fraidenburg D, et al. Red blood cell exchange to avoid intubating a
COVID-19 positive patient with sickle cell disease? J Clin Apher
2020;35:378–81. https://doi.org/10.1002/jca.21809.
[16] Hussain FA, Njoku FU, Saraf SL, Molokie RE, Gordeuk VR, Han J.
COVID-19 infection in patients with sickle cell disease. Br J Haematol
2020;189:851–2. https://doi.org/10.1111/bjh.16734.
[17] Nur E, Gaartman AE, van Tuijn CFJ, Tang MW, Biemond BJ.
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease
due to 2019 novel coronavirus disease (COVID-19). Am J Hematol
2020;95:725–6. https://doi.org/10.1002/ajh.25821.
[18] Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay
D. COVID-19 pneumonia as a cause of acute chest syndrome in an adult
sickle cell patient. Am J Hematol 2020;95:E154–6.
https://doi.org/10.1002/ajh.25809.
[19] De Luna G, Habibi A, Deux JF, Colard M, Pham Hung d’Alexandry
d’Orengiani AL, Schlemmer F, et al. Rapid and severe Covid-19 pneumonia
with severe acute chest syndrome in a sickle cell patient successfully
treated with tocilizumab. Am J Hematol 2020;95:876–8.
https://doi.org/10.1002/ajh.25833.
[20] Allison D, Campbell-Lee S, Crane J, Vidanovic V, Webb S,
Fraidenburg D, et al. Red blood cell exchange to avoid intubating a
COVID-19 positive patient with sickle cell disease? J Clin Apher
2020;35:378–81. https://doi.org/10.1002/jca.21809.
[21] Justino CC, Campanharo FF, Augusto MN, Morais SC de, Figueiredo
MS. COVID-19 as a trigger of acute chest syndrome in a pregnant woman
with sickle cell anemia. Hematol Transfus Cell Ther 2020;42:212–4.
https://doi.org/10.1016/j.htct.2020.06.003.
[22] Quaresima M, Quaresima V, Naldini MM, Cirillo DM, Ferrari A,
Mazzi A, et al. Clinical management of a Nigerian patient affected by
sickle cell disease with rare blood group and persistent SARS-CoV-2
positivity. EJHaem 2020. https://doi.org/10.1002/jha2.53.
[23] Azerad M, Bayoudh F, Weber T, Minon J, Ketelslegers O, Hoyoux
M, et al. Sickle cell disease and COVID‐19: Atypical presentations and
favorable outcomes. EJHaem 2020. https://doi.org/10.1002/jha2.74.
[24] Al-Hebshi A, Zolaly M, Alshengeti A, Al Qurainees G, Yamani S,
Hamdan N, et al. A Saudi family with sickle cell disease presented with
acute crises and COVID-19 infection. Pediatr Blood Cancer 2020;67.
https://doi.org/10.1002/pbc.28547.
[25] Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M,
Joseph L, et al. Prognosis of patients with sickle cell disease and
COVID-19: a French experience. Lancet Haematol 2020;7:e632–4.
https://doi.org/10.1016/S2352-3026(20)30204-0.
[26] McCloskey KA, Meenan J, Hall R, Tsitsikas DA. COVID-19
infection and sickle cell disease: a UK centre experience. Br J Haematol
2020;190:e57–8. https://doi.org/10.1111/bjh.16779.
[27] Balanchivadze N, Kudirka AA, Askar S, Almadhoun K, Kuriakose P,
Fadel R, et al. Impact of COVID-19 Infection on 24 Patients with Sickle
Cell Disease. One Center Urban Experience, Detroit, MI, USA. Hemoglobin
2020. https://doi.org/10.1080/03630269.2020.1797775.
[28] Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B,
et al. Coronavirus Disease among Persons with Sickle Cell Disease,
United States, March 20-May 21, 2020. Emerg Infect Dis 2020;26.
https://doi.org/10.3201/eid2610.202792.